CANCER MARKERS [1] CARCINO EMBRYONIC ANTIGEN (CEA) COMPLETE HEMOGRAM [28] BASOPHILS – ABSOLUTE COUNT EOSINOPHILS – ABSOLUTE COUNT LYMPHOCYTES – […]

CARDIAC [3] Creatine Phosphokinase (CPK), Serum Creatine Phosphokinase Muscle/Brain (CPK MB), Serum NT-PROBNP CARDIAC RISK MARKERS [7] APO B /

CARDIAC RISK MARKERS [5] APO B / APO A1 RATIO (APO B/A1) APOLIPOPROTEIN – A1 (APO-A1) APOLIPOPROTEIN – B (APO-B)

CANCER MARKER [4] CA125 HUMAN EPIDIDYMIS PROTEIN 4 ROMA – PREMENOPAUSAL ROMA – POSTMENOPAUSAL CANCER MARKERS [3] CA 15.3 CA

CARDIAC RISK MARKERS [6] APO B / APO A1 RATIO (APO B/A1) APOLIPOPROTEIN – A1 (APO-A1) APOLIPOPROTEIN – B (APO-B)

CANCER MARKERS [3] CA 19.9 CARCINO EMBRYONIC ANTIGEN (CEA) PROSTATE SPECIFIC ANTIGEN (PSA)

CANCER MARKERS [5] PERCENT FREE PSA CA 19.9 CARCINO EMBRYONIC ANTIGEN (CEA) FREE PSA PROSTATE SPECIFIC ANTIGEN (PSA) COMPLETE HEMOGRAM

CANCER MARKERS [4] CA-125 CA 15.3 CA 19.9 CARCINO EMBRYONIC ANTIGEN (CEA) Pregnancy [1] ALPHA FETO PROTEIN PREGNANCY [1] BETA

CANCER MARKERS [3] CA-125 CA 15.3 CARCINO EMBRYONIC ANTIGEN (CEA)

INFECTIOUS DISEASES [5] CYTOMEGALO VIRUS (CMV) – IgM HERPES SIMPLEX VIRUS I (HSV)-IGM HERPES SIMPLEX VIRUS II (HSV)-IGM RUBELLA –